Close Menu
    Trending
    • American Businessman Mark Eric Williams Vindicated in Six-Year, US$150 Million-Plus Litigation Brought by Kuwaiti State Entities
    • Air Arabia Egypt launches Cairo to Al Ain flights soon
    • TÜV SÜD opens its International Technology & Innovation Campus in the Guangdong-Hong Kong-Macao Greater Bay Area
    • Huawei Unveils Financial AI Scaling Capabilities at Singapore FinTech Festival 2026
    • Botswana opens consultations on proposed 33 percent hike now
    • UnionPay International and Transsion Announce Global Partnership to Bring UnionPay Payments to T Wallet, Debuting in Pakistan
    • Lianlian DigiTech Launches LianLian XWorker, an AI Workforce Platform for Global Commerce
    • PM Modi meets Prince and Princess of Wales for climate talks
    Friday, November 20
    UAE TribuneUAE Tribune
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    UAE TribuneUAE Tribune
    Home » Japanese glucan supplement Nichi GLOW improves autism spectrum disorder behaviors
    Health

    Japanese glucan supplement Nichi GLOW improves autism spectrum disorder behaviors

    March 9, 2022
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    MENA Newswire: March, 2022, Tokyo – In children with autism spectrum disorder (ASD), Beta 1,3 -1,6 glucan (Nichi GLOW) as an adjunct, when orally consumed with conventional therapies, yielded behavioral improvement, documented by Childhood Autism Rating Scale (CARS) score in a pilot clinical study, published in BMJ Neurology Open. Blood levels of Alpha-synuclein, a neurotransmitter and Melatonin increased along with improvement in sleep, learning skills and communication ability.

    Japanese glucan supplement Nichi GLOW improves autism spectrum disorder behaviors

    In the first of its kind report, in a study of 90-days, those who consumed AFO-202 strain of black yeast Aureobasidium Pullulans produced Beta 1,3 -1,6 glucan, had significant beneficial reconstitution of their gut microbiota than control group. Enterobacteria which produces harmful curli and amyloid proteins, causing misfolding of alpha-synuclein were controlled in the Nichi-GLOW group, is a breakthrough, said Dr Raghavan, developmental pediatrician, and neurologist, the first author. These harmful proteins aggregate in the neurons of the gut, propagate to brain through the gut-brain-axis like prions and could cause Parkinsons disease or Alzheimer’s later. This safe food supplement, addressing one of the root-causes by controlling enterobacteria is worth evaluating clinically as a prophylaxis to neurodegenerative diseases, he commented during an international webinar commemorating Autism Sunday.

    Mr. Takashi Onaka, who established the GMP scale exo-polysaccharide production of Nichi Glucan range of products, using the pristine waters of Nyodogawa river, in Kochi, Japan, appreciated the scientific pursuit of Prof. Noboru Fujii of Miyazaki University who explored the poly-extremotolerant nature of the Black yeast, upon isolating and successfully culturing it, in his lab in 1980s. A fungi evaluated for water purification has now evolved as a prebiotic food, with health benefits, he added. Dr Muralidhar Hegde from Houston Methodist Research Institute, USA, Prof. Nobunao Ikewaki from Kyushu University of Health and Welfare, Japan, and Dr Muzafar Gani Abdul Wahab of MacMaster University, Canada, joined the panel discussion.

    Nichi GLOW an approved food additive in Japan since 1996, doesn’t have any commonly known allergens. With a 25 years safety track record, though is not a drug or remedy to any illness, may serve as an adjunct in managing neurodevelopmental and neurodegenerative diseases after validation in different populations, according to the scientists. Clinical studies employing different strains of the product in unmet neurological diseases are underway.

    Related Posts

    Ebola adds 60 cases in a day as Congo deaths hit 5,568

    November 18, 2026

    Ebola cases top 11,200 as Africa CDC warns of record outbreak

    November 16, 2026

    Yellow fever kills 18 across nine African nations, WHO says

    November 7, 2026

    Dengue kills 173 in October as Bangladesh toll climbs to 418

    November 2, 2026

    Ebola death toll in DR Congo nears 4,900 as cases pass 10,000

    October 28, 2026

    Malaria kills 22 in Namibia’s Zambezi Region as cases rise

    October 26, 2026
    Latest News

    Air Arabia Egypt launches Cairo to Al Ain flights soon

    November 20, 2026

    Botswana opens consultations on proposed 33 percent hike now

    November 19, 2026

    PM Modi meets Prince and Princess of Wales for climate talks

    November 19, 2026

    Rand slips toward R17 as inflation and weak growth cloud outlook

    November 18, 2026

    Dubai Airports expects over 70 million guests in 2026

    November 18, 2026

    Ebola adds 60 cases in a day as Congo deaths hit 5,568

    November 18, 2026

    Prabowo says DEFA can unlock $2 trillion ASEAN digital economy

    November 18, 2026

    Over 9 million visitors lift Tunisia tourism income 3.4%

    November 17, 2026
    © 2026 UAE Tribune | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.